# DSS, Inc.: overview

DSS · NYSE · CIK 771999 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dss.md) · [Financials](/companies/dss/financials.md) · [Filings](/companies/dss/filings.md) · [Insiders](/companies/dss/insiders.md)

Latest reported revenue: [$3.6m](/filings/0001493152-26-038447.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 14, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001493152-26-038447).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [5,599](/filings/0001493152-25-023374.md) | [5,416 d](/filings/0001493152-26-014231.md) | [4,954](/filings/0001493152-26-023865.md) | [5,285](/filings/0001493152-26-038447.md) | [6,392](/filings/0001493152-25-023374.md) | [4,127 d](/filings/0001493152-26-014231.md) | [4,331](/filings/0001493152-26-023865.md) | [3,604](/filings/0001493152-26-038447.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [(83.4%)](/filings/0001493152-25-023374.md) | [(522.7%) d](/filings/0001493152-26-014231.md) | [(75.2%)](/filings/0001493152-26-023865.md) | [(64.8%)](/filings/0001493152-26-038447.md) | [(50.6%)](/filings/0001493152-25-023374.md) | [(98.1%) d](/filings/0001493152-26-014231.md) | [(126.7%)](/filings/0001493152-26-023865.md) | [(105.0%)](/filings/0001493152-26-038447.md) |
| Net margin | % | [(94.4%)](/filings/0001493152-24-045198.md) | [(606.8%) d](/filings/0001493152-26-014231.md) | [(96.4%)](/filings/0001493152-26-023865.md) | [(40.7%)](/filings/0001493152-26-038447.md) | [(34.9%)](/filings/0001493152-25-023374.md) | [(335.4%) d](/filings/0001493152-26-014231.md) | [(134.4%)](/filings/0001493152-26-023865.md) | [(132.9%)](/filings/0001493152-26-038447.md) |
| Diluted EPS | $ per share | [(0.75)](/filings/0001493152-24-045198.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Free cash flow | $k | [(315) d](/filings/0001493152-25-023374.md) | [(2,976) d](/filings/0001493152-26-014231.md) | [116](/filings/0001493152-26-023865.md) | [(714) d](/filings/0001493152-26-038447.md) | [(7,204) d](/filings/0001493152-25-023374.md) | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Net income: us-gaap:ProfitLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [20.3](/filings/0001493152-23-010334.md) | [28.4](/filings/0001493152-24-042100.md) | [25.9](/filings/0001641172-25-001576.md) | [19.1](/filings/0001493152-26-014231.md) | [20.8](/filings/0001493152-26-014231.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [(116.0%)](/filings/0001493152-23-010334.md) | [(105.6%)](/filings/0001493152-24-042100.md) | [(195.8%)](/filings/0001641172-25-001576.md) | [(223.1%)](/filings/0001493152-26-014231.md) | [(69.5%)](/filings/0001493152-26-014231.md) |
| Net margin | % | [(163.3%)](/filings/0001493152-23-010334.md) | [(210.8%)](/filings/0001493152-24-042100.md) | [(233.8%)](/filings/0001641172-25-001576.md) | [(245.6%)](/filings/0001493152-26-014231.md) | [(115.3%)](/filings/0001493152-26-014231.md) |
| Diluted EPS | $ per share | [(0.68)](/filings/0001493152-23-010334.md) | [(6.84)](/filings/0001493152-24-042100.md) | [(8.20)](/filings/0001641172-25-001576.md) | [(6.63)](/filings/0001641172-25-001576.md) | not reported |
| Free cash flow | $m | [(23.3)](/filings/0001493152-23-010334.md) | [(28.8)](/filings/0001493152-24-042100.md) | [(20.0)](/filings/0001641172-25-001576.md) | [(8.9)](/filings/0001493152-26-014231.md) | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/dss/insiders.md)

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2024-12-10 | [Chan Heng Fai Ambrose](/insiders/1261725.md) | Director, 10% owner | Purchase (P) | 205,149 | $0.9749 | $200.0k | [Form 4](/filings/0001493152-24-049861.md) |
| 2024-12-10 | [Chan Heng Fai Ambrose](/insiders/1261725.md) | Director, 10% owner | Purchase (P) | 820,597 | $0.9749 | $800.0k | [Form 4](/filings/0001493152-24-049861.md) |
| 2022-07-07 | [Chan Heng Fai Ambrose](/insiders/1261725.md) | Director, 10% owner | Purchase (P) | 17,570,948 | not reported | not reported | [Form 4](/filings/0001493152-22-019013.md) |
| 2022-03-09 | [Chan Heng Fai Ambrose](/insiders/1261725.md) | Director, 10% owner | Purchase (P) | 3,986,877 | $0.381 | $1.5m | [Form 4](/filings/0001493152-22-006557.md) |
| 2021-09-08 | [Chan Heng Fai Ambrose](/insiders/1261725.md) | Director, 10% owner | Purchase (P) | 12,155,591 | $1.234 | $15.0m | [Form 4](/filings/0001493152-21-022444.md) |

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $34.2k | 58,032 |  | Unchanged |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $32.8k | 55,558 |  | Added +55,077 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $16.5k | 27,892 |  | Reduced −26,459 |
| [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $16.0k | 27,048 |  | Reduced −10,194 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $12.4k | 20,977 |  | Unchanged |
| [XTX Topco Ltd](/funds/1828301.md) | 2026-06-30 | $8.5k | 14,323 |  | New +14,323 |
| [Tower Research Capital LLC (TRC)](/funds/1533421.md) | 2026-06-30 | $4.4k | 7,527 |  | Added +2,361 |
| [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $4.0k | 6,802 |  | Unchanged |
| [HRT FINANCIAL LP](/funds/1475597.md) | 2026-06-30 | $123 | 208,481 |  | New +208,481 |
| [WELLS FARGO & COMPANY/MN](/funds/72971.md) | 2026-06-30 | $93 | 157 |  | Unchanged |

## Recent filings

[All 864 filings](/companies/dss/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-20 | 20:16 ET | [DEF 14A](/filings/0001493152-26-047764.md) | Proxy statement, period 2026-10-20 | 0001493152-26-047764 |
| 2026-09-21 | 20:05 ET | [8-K](/filings/0001493152-26-043561.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-043561 |
| 2026-09-08 | 01:14 ET | [SCHEDULE 13D/A](/filings/0001493152-26-041836.md) | Ownership report, active investor, amended | 0001493152-26-041836 |
| 2026-08-14 | 20:31 ET | [10-Q](/filings/0001493152-26-038447.md) | Quarterly report, period 2026-06-30 | 0001493152-26-038447 |
| 2026-07-09 | 21:00 ET | [SCHEDULE 13D/A](/filings/0001493152-26-032713.md) | Ownership report, active investor, amended | 0001493152-26-032713 |
| 2026-06-25 | 20:05 ET | [8-K](/filings/0001493152-26-030115.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-030115 |
| 2026-05-15 | 20:32 ET | [10-Q](/filings/0001493152-26-023865.md) | Quarterly report, period 2026-03-31 | 0001493152-26-023865 |
| 2026-04-24 | 20:05 ET | [S-1/A](/filings/0001493152-26-018910.md) | Registration statement, amended | 0001493152-26-018910 |
| 2026-04-17 | 20:53 ET | [S-1](/filings/0001493152-26-017899.md) | Registration statement | 0001493152-26-017899 |
| 2026-03-31 | 21:00 ET | [8-K](/filings/0001493152-26-014289.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-014289 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001493152-26-014231.md), filed Mar 31, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/91fedecd-5329-46c9-aed9-ba112397bd50)

## About the filer

- CIK: 771999
- Tickers: DSS
- Exchange: NYSE
- SIC code: 2650 Paperboard Containers & Boxes
- State of incorporation: NY
- Filer category: Non-accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.